Research Fellow
Mayo Clinic
Amro M. Abdelrahman, M.B.B.S., M.S., is a postdoctoral research associate in the department of surgery at Mayo Clinic. Dr. Abdelrahman graduated with a doctorate medical degree in 2013 from the University of Khartoum medical school in Sudan. In 2021, he graduated from the Mayo Clinic Graduate School of Biomedical Sciences with a Master of Science in Clinical and Translational Science. Then, he completed a 1-year oncology educational fellowship by the Food and Drug Administration and American Association of Cancer Research (FDA-AACR) on oncology drug development and the regulatory review process. After three years of postdoctoral fellowship with awarded grants on applied human factors and ergonomics research on surgical practice and education, Dr. Abdelrahman shifted his research to cancer research within the Hepatobiliary and Pancreatic Malignancies Patient-Derived Xenograft (PDX) Program in the department of surgery at Mayo Clinic, Rochester, MN. Dr. Abdelrahman had extensive experience generating and validating unique PDX models. Also, Dr. Abdelrahman is an expert in preclinical in vivo treatment trials using PDX models. Over the last two years, Dr. Abdelrahman successfully designed and executed a series of more than 20 large preclinical in-vivo treatment trials of novel targeted therapies and standard-of-care chemotherapies that got into publications or are under review. In addition, Dr. Abdelrahman is studying epidemiology, risk factors, and oncological outcomes of rare, aggressive abdominal malignancies. His current specific research interests focus on the areas of rare abdominal cancers, mainly rare hepatobiliary and pancreatic cancers, and retroperitoneal sarcomas, including the role of new diagnostic modality in cancer staging and the impact of different treatment modalities on the oncological outcomes. Dr. Abdelrahman actively participates in several national and international societies related to cancer, surgery, and human factors. He has more than twenty-eight peer-reviewed publications and more than 50 presentations at regional, national, and international conferences.